UnitedHealth Group Incorporated $UNH Shares Sold by Berbice Capital Management LLC

Berbice Capital Management LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 71.0% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 1,630 shares of the healthcare conglomerate’s stock after selling 4,000 shares during the quarter. UnitedHealth Group accounts for 0.4% of Berbice Capital Management LLC’s investment portfolio, making the stock its 29th biggest position. Berbice Capital Management LLC’s holdings in UnitedHealth Group were worth $509,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. Hemington Wealth Management increased its holdings in shares of UnitedHealth Group by 2.5% during the first quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after purchasing an additional 28 shares during the period. Tlwm increased its stake in UnitedHealth Group by 1.0% during the 1st quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock valued at $1,433,000 after buying an additional 28 shares during the period. Endowment Wealth Management Inc. boosted its holdings in shares of UnitedHealth Group by 5.0% in the first quarter. Endowment Wealth Management Inc. now owns 650 shares of the healthcare conglomerate’s stock valued at $341,000 after acquiring an additional 31 shares in the last quarter. Alesco Advisors LLC lifted its position in UnitedHealth Group by 6.2% in the first quarter. Alesco Advisors LLC now owns 562 shares of the healthcare conglomerate’s stock worth $294,000 after purchasing an additional 33 shares during the period. Finally, Forefront Analytics LLC raised its stake in shares of UnitedHealth Group by 4.2% in the 1st quarter. Forefront Analytics LLC now owns 820 shares of the healthcare conglomerate’s stock worth $430,000 after buying an additional 33 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $324.72 on Wednesday. The stock has a market cap of $294.14 billion, a PE ratio of 16.95, a price-to-earnings-growth ratio of 2.28 and a beta of 0.43. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The business has a fifty day simple moving average of $342.54 and a 200-day simple moving average of $315.53.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period last year, the company posted $7.15 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on UNH. Morgan Stanley lifted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Deutsche Bank Aktiengesellschaft downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a report on Wednesday, October 29th. Truist Financial lifted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Barclays raised their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.